May 07, 2025 7:00am EDT Immunocore reports first quarter financial results and provides a business update
Mar 10, 2025 3:00pm EDT Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025
Feb 26, 2025 7:00am EST Immunocore reports fourth quarter and full year 2024 financial results and provides a business update
Feb 19, 2025 7:00am EST Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025
Jan 10, 2025 7:00am EST Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference
Jan 02, 2025 7:00am EST Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development